Last reviewed · How we verify

NCT03731507: KinectROM

KinectROM Application for Assessing Range of Motion in Upper and Lower Extremity: A Development and Validation Study

Completed NA Last updated 29 July 2020
What this trial tests

NA trial testing Assessment of Range of Motion with Kinect Controller in Range of Motion in 45 participants. Completed in 15 December 2018.

Timeline
5 November 2018
Primary endpoint
30 November 2018
15 December 2018

Quick facts

Lead sponsorSaime Nilay Arman
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment45
Start date5 November 2018
Primary completion30 November 2018
Estimated completion15 December 2018
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Saime Nilay Arman

Who can join

Adults 18 to 40, any sex, with Range of Motion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to investigate the validity and reliability of KinectROM application for objectively evaluating range of motion (ROM)

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Range of Motion

Currently open trials in the same condition.

Other Saime Nilay Arman trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03731507.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing